<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-03T15:52:43Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/0EF5CCC1-2C14-40EE-90FA-ECD23DD0481F" ns1:id="0EF5CCC1-2C14-40EE-90FA-ECD23DD0481F"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/B6E4A3FC-C4BB-4635-9FC4-793ED203F607" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/D4C8648F-D679-4C2D-89ED-3E55D7C01AAF" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/D4C8648F-D679-4C2D-89ED-3E55D7C01AAF" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2014-04-29T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/0EACC61E-107C-43DD-925E-69826E2802AA" ns1:rel="FUND" ns1:start="2013-09-30T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">700269</ns2:identifier></ns2:identifiers><ns2:title>A diagnostic and monitoring device for Diabetic Peripheral Neuropathy</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>GRD Proof of Market</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>An Improved Neuropathy Device
Introduction
Diabetes is burgeoning, especially where cultural changes have favoured “the western diet”:
fast-developing countries are suffering the greatest challenges and would be valuable export
markets. By 2025 there will be 5 m people with diabetes in the UK; up from 3 m diagnosed
today (March 13). The worst complications are to the feet, through Diabetic Peripheral
Neuropathy (DPN), where patients loose feeling, get damage and infection, and then suffer
consequent amputations and a hastened death. This costs the NHS &amp;pound;1billion p.a. and sufferers
extreme hardship.
Aims and objectives
The Putting Feet First campaign from Diabetes UK champions improved screening and
monitoring of DPN to make significant savings to health budgets and improve patients’ lives.
Thermal perception has been shown to deteriorate before other senses. We will deliver a costeffective
screening and monitoring device that can be used in primary care by nurse
practitioners. It will give advanced warning of impending problems and allow early
interventions and personalised care programmes, thereby significantly reducing disease
impact.
This project will:
• Quantify possible savings;
• Identify the size and location of the market;
• Define a realistic price;
• Propose a market strategy;
• Engage with practitioners and patients to confirm the device specifications and
operation.
Description of innovation
We have determined a way of making a portable device accessible to primary care that can
stimulate the patient’s foot with a small plate that drives both hot and cold. It can self-calibrate
and is simple to use, through algorithms and cues. The patient alerts the operator by reporting
their perception of different applied temperatures. After a few minutes of repetition, the
device will indicate a value of the patient’s thermal sensitivity. Their record will allow far
greater visibility and control of the progress and devastating effects of DPN.</ns2:abstractText></ns2:project>